Mapping Interdisciplinary Heart Failure Care Pathways from the Perspectives of Patients and Stakeholders

Mapping Interdisciplinary Heart Failure Care Pathways from the Perspectives of Patients and Stakeholders - HF-MAPS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040978

Enrollment

Registered

2026-07-14

Start date

2026-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50

Interventions

Group 1: Patients diagnosed with heart failure are interviewed once, in a one-on-one setting, about their experiences with heart failure care. Group 2: Stakeholders – that is, those involved in the ca

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Refers to the following group of patients: - Minimum age: 50 years - patients diagnosed with heart failure

Exclusion criteria

Exclusion criteria: - if participants do not consent to an audio recording of the interview

Design outcomes

Primary

Measure	Time frame
Due to the study design, no endpoints in the traditional sense have been defined. The goal of this project is to answer the following research question: How do patients and stakeholders describe existing heart failure care pathways? To achieve this research goal, a qualitative study in the form of guided individual interviews is planned, in which patients and stakeholders will be interviewed separately. The stakeholder interviews are scheduled to be conducted by the end of 2026, and the patient interviews will begin at the end of 2026.	—

Measure

Time frame

Due to the study design, no endpoints in the traditional sense have been defined. The goal of this project is to answer the following research question: How do patients and stakeholders describe existing heart failure care pathways? To achieve this research goal, a qualitative study in the form of guided individual interviews is planned, in which patients and stakeholders will be interviewed separately. The stakeholder interviews are scheduled to be conducted by the end of 2026, and the patient interviews will begin at the end of 2026.

—

Countries

Germany

Contacts

Public ContactMarco Roos

Universitätsklinikum Augsburg

marco.roos@med.uni-augsburg.de+49 821 400 9560

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026